ArticleOncology letters2026

Long-term effects of using pegylated recombinant human granulocyte colony-stimulating factor following chemotherapy: A real-world study on patients with ovarian cancer.

Weimin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.